Purchase Order 75D30124P18698

Award Date 4/24/24
Potential Completion Date 6/30/25
Potential Value $249K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $481,380.00 firm fixed-price definitive contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, to perform a "Prospective Assessment of Neurologic Manifestations of SARS-CoV-2 Infection in Hospitalized Patients." The contract does not have a set-aside designation and is scheduled for completion by August 31, 2023. As a...
This is a $2,205,550.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York to provide support for translational and operational science and technology to improve the CDC. The contract has an ultimate completion date of September 12, 2024 and was awarded on September 13, 2022. This contract is not set aside. Columbia University, a leading academic research institution, will leverage...
The Centers for Disease Control and Prevention (CDC) awarded a $246,462 firm-fixed-price purchase order to The Trustees of Columbia University in the City of New York, Health Sciences Division, to conduct a MPOX self-collection study. The contract has a period of performance through September 14, 2024 and does not have a set-aside designation. Columbia University is a private university and non-profit organization with extensive experience conducting biomedical research and providing services to...
This is a firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York (Columbia University) for an NHSN Adoption Study. The contract has a ceiling value of $371,995.00 and a completion date of September 19, 2018. The contract was not set aside for any specific designation. Columbia University is a renowned private research institution that frequently collaborates with federal agencies through both...
The Centers for Disease Control and Prevention (CDC) awarded a $249,572 firm fixed price purchase order to The Trustees of Columbia University in the City of New York, operating as the Health Sciences Division, to conduct a MPOX viral persistency study. As the prime contractor, Columbia University will perform the study under the contract's one-year period of performance in New York, New York. The CDC aims to enhance understanding of MPOX through research administered under its broader health...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $465,467 firm fixed-price definitive contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, to provide multifaceted control strategies for seasonal and pandemic influenza. The contract has a completion date of January 31, 2021 and was awarded on August 1, 2019. This contract is not set aside for any special designation. The Trustees of...
This is a delivery order contract awarded to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, by the Centers for Disease Control and Prevention (CDC). The $774,425 contract is for the CISA RSV INFANTS STUDY (CONTRIBUTING SITE) and does not have a set-aside designation. The contract is a cost-no-fee type with a period of performance through September 26, 2027. As a leading research institution, Columbia University has extensive...
The Centers for Disease Control and Prevention (CDC) awarded a $91,531.27 Firm Fixed Price contract to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, for a LAMP STUDY project. This is a Definitive Contract with an ultimate completion date of August 7, 2024. The contract is not set aside. The Trustees of Columbia University, the prime contractor, is a renowned private research institution that regularly partners with government...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a private university and non-profit organization. The $499,857 Delivery Order is part of the CDC's Clinical Immunization Safety Assessment (CISA) indefinite delivery contract, which supports ongoing monitoring and evaluation of vaccine safety as part of the agency's disease prevention...
The Centers for Disease Control and Prevention awarded a $154,876 delivery order contract to The Trustees of Columbia University in New York, New York. The contract supports research entitled "TB in the U.S.: Epidemiology and Prevention Opportunities" through September 14, 2010. As a private, non-profit educational institution, Columbia University will provide subject matter expertise and analysis to the CDC regarding tuberculosis trends, transmission dynamics, and strategies for...

The Centers for Disease Control and Prevention (CDC) awarded a $249,000 firm fixed-price purchase order to The Trustees of Columbia University in the City of New York to conduct a prospective long-term follow-up study on COVID-19 patients who developed neurological manifestations, with a focus on Hispanic/Latinx populations. The study aims to recruit 150 participants and collect and analyze data on neurocognitive effects, biomarkers, and neuroradiological features over 24 months. This sole-source award was justified under the authority of 41 U.S.C. 3304(a)(2) for unusual and compelling urgency, as the CDC was unable to modify an existing contract with Columbia University. There is no set-aside designation for this contract. Columbia University, through its Health Sciences Division, is a leading research institution experienced in conducting biomedical research, providing healthcare services, and performing program evaluations for federal agencies like the CDC, Department of Health and Human Services, and Department of Defense.

Generated 3/11/25, 9:48 AM